Overview

A Single Oral Dose Study to Evaluate Four Different Formulations of AZD9977 and the Effect of Food in Healthy Male Subjects

Status:
Completed
Trial end date:
2018-06-06
Target enrollment:
Participant gender:
Summary
This study will evaluate pharmacokinetics (PK) of four different formulations with different release profiles of AZD9977 (PART A) in the fasted state, and one of the formulation will be selected for further development (Part B). In Part B, the influence of food on the PK of AZD9977 will be evaluated
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Collaborator:
Parexel